Article
Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus
18 Dec 2001
Abstract excerpt
Transgenic mice expressing MyrAkt from a proximal Lck promoter construct develop thymomas at an early age, whereas transgenic mice expressing constitutively active Lck-AktE40K develop primarily tumors of the peripheral lymphoid organs later in life. The thymus of 6- to 8-week-old MyrAkt transgenic mice is normal in size but contains fewer, larger cells than the thymus of nontransgenic control and AktE40K...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
